He received his M.D. from the Vanderbilt University School of Medicine in 1997 and completed an Internal Medicine residency at Duke University Medical Center, a fellowship in General Internal Medicine at Brigham and Women’s Hospital, and a Master’s of Public Health degree at the Harvard School of Public Health. Since joining the faculty at Vanderbilt, Dr. Peterson has developed programs in personalized medicine to improve drug safety and efficacy and translate genomic technologies to routine clinical care. He directs the evaluation a large-scale pharmacogenomics quality improvement initiative – PREDICT (Pharmacogenomic Resource for Enhanced Decisions In Care and Treatment). Dr. Peterson’s work receives funding by the NHLBI, the Center for Disease Control, the NIH Pharmacogenomics Research Network and NHGRI’s eMERGE program.